GILD: 吉利德科学

GILD新闻

• 11:45 Bristol-Myers Squibb: Why I'm Bullish Ahead Of Q3 Earnings (NYSE:BMY)
• 20:33 Stocks Finish Mostly Higher on Earnings Optimism
• 15:25 Stocks Rebound on Strong Earnings and Lower Bond Yields
• 14:09 Stocks Pressured by Tech Stock Weakness and Higher Crude Oil Prices
• 10:53 B of A Securities Maintains Buy on Gilead Sciences, Raises Price Target to $172
• 10:53 B of A 证券维持对吉利德科学的“买入”评级，将目标价上调至 172 美元
• 18:07 Gilead Bolsters Inflammatory Bowel Disease Pipeline With Promising Mid-Stage Trial Success
• 18:07 吉利德凭借有前景的中期试验成功加强炎症性肠病研发管线
• 15:00 All You Need to Know About Gilead (GILD) Rating Upgrade to Buy
• 10:08 Gilead Announces Emvistegrast 200 Mg Met Primary Endpoint In Phase 2 Swift Dose-Ranging Study; Demonstrated Significant Differences Across Multiple Secondary Measures Of Disease Activity Based On Nominal P-Values; Plans To Initiate Phase 3 Emvistegrast...
• 10:08 吉利德宣布 Emvistegrast 200 毫克在 II 期 Swift 剂量范围研究中达到主要终点；基于名义 P 值，在多项疾病活动度次要指标上显示出显著差异；计划于 2027 年启动 Emvistegrast 单药 III 期研究
• 15:00 Meta, Tesla Headline Earnings In Busy Week For Markets
• 21:00 Gilead Sciences (GILD) Rises Higher Than Market: Key Facts
• 20:34 Stocks Settle Mixed as Broader Market Recovers from Chip Stock Rout
• 18:25 Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
• 17:17 Can Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth?
• 15:27 Stock Indexes Rebound as Investors Rotate Out of Chip Stocks
• 14:18 Stocks Pressured as Chipmaker Selloff Deepens
• 12:00 Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
• 20:36 Stocks Sharply Lower on Inflation Woes and Slumping Chipmakers
• 20:01 S&P 500 Top Stock Gainers Today, 10/14/26 - TipRanks.com
• 16:58 Vir Biotechnology, Gilead Strike Deal for Novel Tumor Treatments
• 16:58 Vir生物技术与吉利德达成新型肿瘤治疗合作协议
• 15:18 Stocks and Bonds Fall on a Strong CPI Report